Citron Questions Inovio's 'Robust' Preclinical Coronavirus Vaccine Announcement, Sees 90% Downside AheadBenzinga • 05/20/20
Results From Oxford University's Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna StandBenzinga • 05/14/20
INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo® (cemiplimab) Demonstrates 85% of Newly Diagnosed Glioblastoma Patients Are Alive 12 Months Following TreatmentPRNewsWire • 05/14/20
Inovio Analysts Tackle Coronavirus Vaccine Timeline, Funding, Pipeline After Q1 ReportBenzinga • 05/12/20
Inovio Pharmaceuticals, Inc. (INO) CEO J. Joseph Kim on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/12/20